BIOMAT Database Logo BIOMAT Database Logo

Conformation of actinomycin-D. 1970

F Conti, and P De Santis

UI MeSH Term Description Entries
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008961 Models, Structural A representation, generally small in scale, to show the structure, construction, or appearance of something. (From Random House Unabridged Dictionary, 2d ed) Model, Structural,Structural Model,Structural Models
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen

Related Publications

F Conti, and P De Santis
Solvent effect on the conformation of actinomycin D.
September 1970, Nature,
F Conti, and P De Santis
NMR study of the solution conformation of actinomycin D.
October 1992, European journal of biochemistry,
F Conti, and P De Santis
Solution conformation of the actinomycin D related pentapeptide lactone using NMR and molecular modeling.
October 1989, Biopolymers,
F Conti, and P De Santis
[Actinomycin D-o].
February 1974, Antibiotiki,
F Conti, and P De Santis
Crystal Structures of Actinomycin D and Actinomycin Z3.
September 1998, Angewandte Chemie (International ed. in English),
F Conti, and P De Santis
Hepatotoxicity of actinomycin-D.
January 1989, Lancet (London, England),
F Conti, and P De Santis
Regulation of gene expression by actinomycin D and other compounds which change the conformation of DNA.
October 1969, Archives of biochemistry and biophysics,
F Conti, and P De Santis
[Actinomycin D derivatives that recognize 2 DNA GC pairs: bis-actinomycin D].
January 1981, Doklady Akademii nauk SSSR,
F Conti, and P De Santis
Actinomycin D Inhibition of Vitamin D Action.
July 1965, Science (New York, N.Y.),
F Conti, and P De Santis
Actinomycin D-induced hepatotoxicity.
January 1989, Pediatric hematology and oncology,
Copied contents to your clipboard!